A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients with Moderate to Severe Atopic Dermatitis. (2018). SKIN The Journal of Cutaneous Medicine, 2(S1), S29. https://doi.org/10.25251/skin.2.supp.28